After release, it stimulates the expression of immunosuppressive ligands (PD-L1, PD-L2) on tumor-associated fibroblasts, which causes suppression of melanoma-specific CD8+ T cells [86]. The gene discussed is PDCD1LG2; the disease is neoplasm.